{"id":56242,"date":"2025-12-08T20:28:19","date_gmt":"2025-12-08T14:58:19","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=56242"},"modified":"2025-12-08T20:28:43","modified_gmt":"2025-12-08T14:58:43","slug":"corona-remedies-ipo-subscription-day-1","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/corona-remedies-ipo-subscription-day-1\/","title":{"rendered":"Corona Remedies IPO Subscription Day 1"},"content":{"rendered":"<p>Here, the Corona Remedies IPO launched on 8th December 2025. Bidding for the issue will close today, 10th December 2025. The primary aim of the <strong>Corona Remedies IPO<\/strong> is to raise \u20b9655.37 crores from the market. Also, the Corona Remedies IPO has received an impressive level of subscription, indicating that the shares will be listed at an impeccable premium. Scroll down to check the Corona Remedies IPO subscription and details.&nbsp;<\/p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/corona-remedies-ipo-subscription-day-1\/#Corona_Remedies_IPO_Details\" title=\"Corona Remedies IPO Details&nbsp;\">Corona Remedies IPO Details&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/corona-remedies-ipo-subscription-day-1\/#Corona_Remedies_IPO_Subscription_Status\" title=\"Corona Remedies IPO Subscription Status\">Corona Remedies IPO Subscription Status<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/corona-remedies-ipo-subscription-day-1\/#Corona_Remedies_IPO_GMP_Today\" title=\"Corona Remedies IPO GMP Today\">Corona Remedies IPO GMP Today<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/corona-remedies-ipo-subscription-day-1\/#About_Corona_Remedies_Ltd\" title=\"About Corona Remedies Ltd.\">About Corona Remedies Ltd.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/corona-remedies-ipo-subscription-day-1\/#Corona_Remedies_Limited_Financials\" title=\"Corona Remedies Limited Financials\">Corona Remedies Limited Financials<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/corona-remedies-ipo-subscription-day-1\/#Explanation\" title=\"Explanation\">Explanation<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/corona-remedies-ipo-subscription-day-1\/#Technical_Indicators\" title=\"Technical Indicators\">Technical Indicators<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/corona-remedies-ipo-subscription-day-1\/#Corona_Remedies_IPO_Listing_Expectations\" title=\"Corona Remedies IPO Listing Expectations\">Corona Remedies IPO Listing Expectations<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/corona-remedies-ipo-subscription-day-1\/#Corona_Remedies_IPO_Dates\" title=\"Corona Remedies IPO Dates\">Corona Remedies IPO Dates<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/corona-remedies-ipo-subscription-day-1\/#Recent_Articles\" title=\"Recent Articles\">Recent Articles<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Corona_Remedies_IPO_Details\"><\/span><strong>Corona Remedies IPO Details&nbsp;<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>IPO Open Date<\/strong><\/td><td>8th December 2025<\/td><\/tr><tr><td><strong>Face Value&nbsp;<\/strong><\/td><td>\u20b910 per share<\/td><\/tr><tr><td><strong>Price Band<\/strong><\/td><td>\u20b9131 to \u20b9138 per share<\/td><\/tr><tr><td><strong>Lot Size<\/strong><\/td><td>14 Shares<\/td><\/tr><tr><td><strong>Issue Type<\/strong><\/td><td>Bookbuilding Issue<\/td><\/tr><tr><td><strong>Listing At<\/strong><\/td><td>BSE &amp; NSE&nbsp;<\/td><\/tr><tr><td><strong>IPO Close Date&nbsp;<\/strong><\/td><td>10th December 2025<\/td><\/tr><tr><td><strong>Listing Date&nbsp;<\/strong><\/td><td>15th December 2025<\/td><\/tr><\/tbody><\/table><\/figure><p>The price band for Riddhi Display Equipment&#8217;s IPO has been set at \u20b91,008 to \u20b91,062 per share, and a total of 14 shares are being issued. Let&#8217;s segregate the share quota fixed for different categories of investors.&nbsp;<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Investor Category<\/strong><\/td><td><strong>Shares Offered<\/strong><\/td><td><strong>Shares Subscribed<\/strong><\/td><td><strong>Subscription to the Times<\/strong><\/td><\/tr><tr><td><strong>QIB shares offered<\/strong><\/td><td>Not more than 50% of the Net Offer<\/td><td>30,56,533<\/td><td>49.53<\/td><\/tr><tr><td><strong>NII (HNI) Shares Offered<\/strong><\/td><td>Not less than 15% of the Net Offer<\/td><td>9,16,960<\/td><td>14.86<\/td><\/tr><tr><td><strong>Retail Shares Offered<\/strong><\/td><td>Not less than 35% of the Net Offer<\/td><td>21,39,573<\/td><td>34.67<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Corona_Remedies_IPO_Subscription_Status\"><\/span><strong>Corona Remedies IPO Subscription Status<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>As of now, the Corona Remedies IPO has been subscribed to 0.67 times. Of these, 0.95 times are subscribed by retail investors, 0.84 times by non-institutional investors, and 1.07 times by OIB (Qualified-Institutional Buyers).&nbsp;&nbsp;<\/p><p>The healthy subscription status indicates that investors are expecting higher returns at the time of Riddhi Display Equipment&#8217;s IPO listing on 15th December 2025. Corona Remedies also has a positive outlook behind the fresh issue of shares, which will raise around Rs 655.37&nbsp; crores.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Corona_Remedies_IPO_GMP_Today\"><\/span><strong>Corona Remedies IPO GMP Today<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-image size-large\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"536\" src=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/08202654\/Corona-Remedies-IPO-GMP-1024x536.jpg\" alt=\"\" class=\"wp-image-56244\" srcset=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/08202654\/Corona-Remedies-IPO-GMP-1024x536.jpg 1024w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/08202654\/Corona-Remedies-IPO-GMP-300x157.jpg 300w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/08202654\/Corona-Remedies-IPO-GMP-768x402.jpg 768w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/08202654\/Corona-Remedies-IPO-GMP-900x471.jpg 900w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/08202654\/Corona-Remedies-IPO-GMP-600x314.jpg 600w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/08202654\/Corona-Remedies-IPO-GMP-150x79.jpg 150w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/08202654\/Corona-Remedies-IPO-GMP.jpg 1200w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><p>We know that higher subscription levels drive grey-market premiums for IPOs. Let\u2019s explore the Corona Remedies IPO GMP for 8th December 2025.&nbsp;<\/p><p>The grey market premium for this IPO has surged to 0.00% or Rs 138.00 per share. It indicates that the estimated listing price per share is Rs 138.00. Numerous factors played a pivotal role in this jump in the GMP of Corona Remedies IPO. These include higher subscription rates, favourable market sentiment, and investors&#8217; positive attitude towards IPOs.&nbsp;<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>GMP Date<\/strong><\/td><td><strong>IPO Price<\/strong><\/td><td><strong>GMP<\/strong><\/td><td><strong>Estimated Listing Price&nbsp;<\/strong><\/td><td><strong>Estimated Listing Gains<\/strong><\/td><\/tr><tr><td><strong>8-12-2025<\/strong><\/td><td>\u20b9138.00<\/td><td>\u20b90.00<\/td><td>\u20b9138.00<\/td><td>0.00%<\/td><\/tr><tr><td><strong>7-12-2025<\/strong><\/td><td>\u20b9138.00<\/td><td>\u20b90.00<\/td><td>\u20b9138.00<\/td><td>0.00%<\/td><\/tr><tr><td><strong>6-12-2025<\/strong><\/td><td>\u20b9138.00<\/td><td>\u20b90.00<\/td><td>\u20b9138.00<\/td><td>0.00%<\/td><\/tr><tr><td><strong>5-12-2025<\/strong><\/td><td>\u20b9138.00<\/td><td>\u20b90.00<\/td><td>\u20b9138.00<\/td><td>0.00%<\/td><\/tr><tr><td><strong>4-12-2025<\/strong><\/td><td>\u20b9138.00<\/td><td>\u20b90.00<\/td><td>\u20b9138.00<\/td><td>0.00%<\/td><\/tr><tr><td><strong>3-12-2025<\/strong><\/td><td>\u20b9138.00<\/td><td>\u20b90.00<\/td><td>\u20b9138.00<\/td><td>0.00%<\/td><\/tr><tr><td><strong>2-12-2025<\/strong><\/td><td>\u20b9138.00<\/td><td>\u20b90.00<\/td><td>\u20b9138.00<\/td><td>0.00%<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"About_Corona_Remedies_Ltd\"><\/span><strong>About Corona Remedies Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Corona Remedies was established in August 2004. Corona Remedies Limited is a pharmaceutical company developing, manufacturing, and marketing products in women\u2019s healthcare, cardiology, pain management, urology, and other therapeutic areas. As of June 30, 2025, the company&#8217;s diverse portfolio includes 71 brands across therapeutic areas like women\u2019s healthcare, cardio-diabeto, pain management, urology, and multispecialty pharmaceuticals (including vitamins\/minerals\/nutrition, gastrointestinal, and respiratory). The company has a pan-India marketing and distribution network with 2,671 medical representatives across 22 states, enabling effective engagement with healthcare professionals and hospitals, consolidating its presence in the IPM, and ensuring deep penetration across therapeutic areas.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Corona_Remedies_Limited_Financials\"><\/span><strong>Corona Remedies Limited Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>The company&#8217;s financial analysis is essential before applying for the<strong> Corona Remedies IPO. <\/strong>Look at the table to learn about Corona Remedies Limited&#8217;s financials.&nbsp;<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Year Ended<\/strong><\/td><td><strong>30th June 2025 (in cr.)<\/strong><\/td><td><strong>31st March 2025 (in cr.)<\/strong><\/td><td><strong>31st March 2024<\/strong><\/td><\/tr><tr><td><strong>Assets<\/strong><\/td><td>1,012.38<\/td><td>929.86<\/td><td>830.58<\/td><\/tr><tr><td><strong>Revenue<\/strong><\/td><td>348.56<\/td><td>1,202.35<\/td><td>1,020.93<\/td><\/tr><tr><td><strong>Profit After Tax<\/strong><\/td><td>46.20<\/td><td>149.43<\/td><td>90.50<\/td><\/tr><tr><td><strong>EBITDA<\/strong><\/td><td>71.80<\/td><td>245.91<\/td><td>161.19<\/td><\/tr><tr><td><strong>Net Worth<\/strong><\/td><td>607.02<\/td><td>606.34<\/td><td>480.41<\/td><\/tr><tr><td><strong>Reserves and Surplus<\/strong><\/td><td>545.86<\/td><td>545.18<\/td><td>419.25<\/td><\/tr><tr><td><strong>Total Borrowings<\/strong><\/td><td>106.65<\/td><td>62.70<\/td><td>134.14<\/td><\/tr><\/tbody><\/table><\/figure><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Explanation\"><\/span><strong>Explanation<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Corona Remedies Limited&#8217;s revenue soared by 18% from \u20b91,020.93 crores in March 2024&nbsp; to \u20b91,202.35 crores in March 2025. Moreover, the company&#8217;s PAT increased by 65% from \u20b990.50 crores in March 2024 to \u20b9149.43 crores in March 2025.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Technical_Indicators\"><\/span><strong>Technical Indicators<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Several technical indicators are available to assess a company&#8217;s potential to deliver returns. Use the parameters mentioned below to analyse the technical aspects of the <strong>Corona Remedies IPO.<\/strong><\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Key Indicators<\/strong><\/td><td><strong>Value<\/strong><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/price-to-earnings-ratio-p-e-ratio\"><strong>PE Ratio (Price-to-Earnings)<\/strong><\/a><strong>&nbsp;<\/strong><\/td><td>43.47<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/earnings-per-share-eps-formula\"><strong>EPS (Earnings Per Share)<\/strong><\/a><\/td><td>24.23<\/td><\/tr><tr><td><strong>RoNW<\/strong><\/td><td>24.65%<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/return-on-capital-employed\"><strong>ROCE<\/strong><\/a><\/td><td>41.32%<\/td><\/tr><tr><td><strong>ROE<\/strong><\/td><td>27.50%<\/td><\/tr><tr><td><strong>EBITDA Margin<\/strong><\/td><td>20.55%<\/td><\/tr><tr><td><strong>Price to Book Value<\/strong><\/td><td>10.71<\/td><\/tr><tr><td><strong>Market Capitalisation<\/strong><\/td><td>\u20b96,495.20<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Corona_Remedies_IPO_Listing_Expectations\"><\/span><strong>Corona Remedies IPO Listing Expectations<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Corona Remedies IPO Highlights: IPO allotment is still pending, as the bid will close today. However, given the current GMP or market sentiment, it is reasonable to expect higher listing gains for the share. A jump of 1.00% in Yash Highlight GMP suggests the estimated listing price per share will be around Rs 138.00.<\/p><p>It will provide higher listing gains to investors who applied for this IPO. Also, the financial fundamentals of this business made it the experts\u2019 top long-term recommendation.&nbsp;<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Corona_Remedies_IPO_Dates\"><\/span><strong>Corona Remedies IPO Dates<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>IPO Open Date<\/strong><\/td><td>8th December 2025<\/td><\/tr><tr><td><strong>IPO Close Date<\/strong><\/td><td>10th December 2025<\/td><\/tr><tr><td><strong>Allotment<\/strong><\/td><td>11th December 2025<\/td><\/tr><tr><td><strong>Refund Date<\/strong><\/td><td>12th December 2025<\/td><\/tr><tr><td><strong>IPO Listing Date<\/strong><\/td><td>15th December 2025<\/td><\/tr><\/tbody><\/table><\/figure><p><strong>Note<\/strong>: IPO GMP is volatile and depends on market sentiment. Hence, one should conduct their research before investing in it.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Articles\"><\/span><strong>Recent Articles<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/blogs\/iicodex-publishing-solutions-ipo-gmp\">Icodex Publishing Solutions IPO GMP: Day 1 IPO Live Updates<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/bluestone-jewellery-ipo-gmp\">Bluestone Jewellery IPO GMP: Day 1 IPO Live Updates<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/highway-infrastructure-ipo-listing-preview\">Highway Infrastructure IPO Listing Preview: What to Expect Now in 2025?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/concord-biotech-q1-results-fy26\">Concord Biotech Q1 Results FY26: Q1 PAT Falls 26.07% to \u20b944.06 Crore; Revenue Down 5.47% YoY<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/action-construction-equipment-q1-results-fy26\">Action Construction Equipment Q1 Results FY26: Q1 PAT Rises 16.08% to \u20b997.72 Crore; Revenue Down 11.19% YoY<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/sawaliya-foods-products-ipo-allotment-status\">Sawaliya Foods Products IPO Allotment Status Check Online: GMP, Subscription, Price, and More<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/jsw-cement-ipo-allotment-status\">Corona Remedies IPO Allotment Status Check Online: GMP, Subscription, Price, and More<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/mahendra-realtors-ipo\">Mahendra Realtors IPO GMP &amp; Review: Apply or Avoid?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/regaal-resources-ipo\">Regaal Resources IPO GMP &amp; Review: Apply or Avoid?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/icodex-publishing-solutions-ipo\">Icodex Publishing Solutions IPO GMP &amp; Review: Apply or Avoid?<\/a><\/p><p><\/p>","protected":false},"excerpt":{"rendered":"<p>Here, the Corona Remedies IPO launched on 8th December 2025. Bidding for the issue will close today, 10th December 2025. The primary aim of the Corona Remedies IPO is to raise \u20b9655.37 crores from the market. Also, the Corona Remedies IPO has received an impressive level of subscription, indicating that the shares will be listed<\/p>\n","protected":false},"author":23,"featured_media":56243,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1281],"tags":[3629],"class_list":["post-56242","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ipo","tag-corona-remedies-ipo-subscription"],"metadata":{"_edit_lock":["1765205923:23"],"_last_editor_used_jetpack":["block-editor"],"rank_math_internal_links_processed":["1"],"amazonS3_cache":["a:4:{s:75:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2025\/12\/Corona-Remedies-IPO-GMP.jpg\";a:2:{s:2:\"id\";i:56244;s:11:\"source_type\";s:13:\"media-library\";}s:84:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2025\/12\/Corona-Remedies-IPO-GMP-1024x536.jpg\";a:2:{s:2:\"id\";i:56244;s:11:\"source_type\";s:13:\"media-library\";}s:107:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/08202654\/Corona-Remedies-IPO-GMP.jpg\";a:2:{s:2:\"id\";i:56244;s:11:\"source_type\";s:13:\"media-library\";}s:116:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/08202654\/Corona-Remedies-IPO-GMP-1024x536.jpg\";a:2:{s:2:\"id\";i:56244;s:11:\"source_type\";s:13:\"media-library\";}}"],"rank_math_primary_category":["1281"],"rank_math_seo_score":["78"],"rank_math_title":["Corona Remedies IPO Subscription Status Day 1: Check Online"],"rank_math_description":["Check the Corona Remedies IPO subscription status online and also get live GMP details and reviews to anticipate the listing gains. Explore for further information about the Corona Remedies IPO. \r\n"],"rank_math_focus_keyword":["Corona Remedies IPO"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_thumbnail_id":["56243"],"_edit_last":["23"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["5031"],"_wp_page_template":["default"],"rs_page_bg_color":[""],"rank_math_canonical_url":["https:\/\/univest.in\/blogs\/corona-remedies-ipo-subscription-day-1"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/12\/08202418\/Corona-Remedies-IPO-Subscription-Status-Day-1.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/56242","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=56242"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/56242\/revisions"}],"predecessor-version":[{"id":56245,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/56242\/revisions\/56245"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/56243"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=56242"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=56242"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=56242"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}